Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs ES✓SelectedUSD · ESGSK vs ES performance historyLatest closeAs of-1.93%09/04
Stock and ETF performance explorer

GSK vs ES

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+1,705.8%
ES return
+1,243.3%
Excess return
+462.6%
Maximum drawdown
-55.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioESExcessAlpha
1D-1.9%-0.6%-1.3%-1.8%
7D-1.8%+0.3%-2.1%-1.9%
30D-2.2%-2.0%-0.2%-1.7%
3M-1.8%+1.7%-3.5%-2.3%
6M-10.6%-3.5%-7.1%-9.9%
YTD+4.4%+7.9%-3.5%+2.0%
1Y+30.4%+17.2%+13.3%+24.1%
3Y+60.1%+29.3%+30.8%+46.5%
5Y+46.8%-5.7%+52.5%+45.0%
10Y+79.2%+85.2%-6.0%+46.2%
All+1,705.8%+1,243.3%+462.6%+714.9%

Cumulative growth

Daily Returns

Daily percentage return beside ES.

Daily Out/Under-Performance

Portfolio return minus ES return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × ES return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded ES wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling